Publications by authors named "Meri Ramela"

Claim this Profile
F
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis.
Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela

Mol Cancer Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Absorption of Naloxone from Eye Drops.
Johanna Tuunainen, Lasse Saloranta, Jouko Levijoki, Jenni Lindstedt, Jenni Lehtisalo, Meri Ramela

Pharmaceuticals (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1.
Riikka Oksala, Anu Moilanen, Reetta Riikonen, Petteri Rummakko, Arja Karjalainen, Meri Ramela

J Steroid Biochem Mol Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of intravenous levosimendan and its metabolites in subjects with hepatic impairment.
Jaakko Puttonen, Sampo Kantele, Angela Ruck, Meri Ramela, Sari Häkkinen

J Clin Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.
Jaakko Puttonen, Tarmo Laine, Meri Ramela, Sari Häkkinen, Wenhui Zhang

Eur J Pharm Sci· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis